 | • レポートコード：D0804-16127 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、142ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、筋骨格系医療の世界市場を広く調査・分析し、今後の市場展望をまとめております。筋骨格系医療の種類別市場規模（錠剤、パッチ剤、カプセル剤、坐剤、注射剤、懸濁剤、アンプラストラム、顆粒剤、その他）、用途別市場規模（整形外科鎮痛薬、解熱鎮痛薬、非ステロイド系抗炎症薬、リウマチ性疾患用薬、痛風薬耐性、あざ用薬、重症筋無力症薬、遅発性抗リウマチ薬、関節・筋肉痛用局所投与、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Mylan N.V.、Dr. Reddy's Laboratories Ltd.、Novartis Pharmaceuticals、Teva Pharmaceutical Industries Ltd、Valeant Pharmaceuticals International, Inc、UCB S.A.、Sawai PharmaceuticalCo., Ltd、Hospira Inc、Roche Inc、Sun Pharmaceutical Industries Ltd. Co. , Ltd、Merck、Bayer、Endo International、Grunenthal、GSK、Boehringer Ingelheim、Hikma Pharmaceuticals、Rafa Laboratories、Alter、Fresenius Kabi, LLC、CorePharma、Pfizer、Apotex Inc、Acorda Therapeutics、Therabel、Martec USA LLC、Sinopharm、Sanofi、Helsinn、Italfarmaco、Chinoin ・地域別グローバル市場分析 2015年-2020年 ・筋骨格系医療の北米市場（アメリカ、カナダ、メキシコ） ・筋骨格系医療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・筋骨格系医療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・筋骨格系医療の南米市場（ブラジル、アルゼンチン） ・筋骨格系医療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：錠剤、パッチ剤、カプセル剤、坐剤、注射剤、懸濁剤、アンプラストラム、顆粒剤、その他 ・用途別分析：整形外科鎮痛薬、解熱鎮痛薬、非ステロイド系抗炎症薬、リウマチ性疾患用薬、痛風薬耐性、あざ用薬、重症筋無力症薬、遅発性抗リウマチ薬、関節・筋肉痛用局所投与、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Musculoskeletal Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Musculoskeletal Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Musculoskeletal Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Musculoskeletal Medicine market has been segmented into:
Tablets
Patch
Capsule
Suppositories
Injection
Suspension Agent
Emplastrum
Granules
Other
By Application, Musculoskeletal Medicine has been segmented into:
Orthopedic Analgesics
Antipyretic And Analgesic
Nonsteroidal Anti-Inflammatory Drugs
Drugs For Rheumatic Diseases
Gout Drug Resistance
Medication For Bruising Injuries
Myasthenia Gravis Medication
Slow Acting Antirheumatic Agent
Topical Administration For Joint And Muscle Pain
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Musculoskeletal Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Musculoskeletal Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Musculoskeletal Medicine market.
The report offers in-depth assessment of the growth and other aspects of the Musculoskeletal Medicine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Musculoskeletal Medicine Market Share Analysis
Musculoskeletal Medicine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Musculoskeletal Medicine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Musculoskeletal Medicine sales, revenue and market share for each player covered in this report.
The major players covered in Musculoskeletal Medicine are:
Mylan N.V.
Dr. Reddy’s Laboratories Ltd.
Novartis Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Valeant Pharmaceuticals International, Inc
UCB S.A.
Sawai PharmaceuticalCo., Ltd
Hospira Inc
Roche Inc
Sun Pharmaceutical Industries Ltd. Co. , Ltd
Merck
Bayer
Endo International
Grunenthal
GSK
Boehringer Ingelheim
Hikma Pharmaceuticals
Rafa Laboratories
Alter
Fresenius Kabi, LLC
CorePharma
Pfizer
Apotex Inc
Acorda Therapeutics
Therabel
Martec USA LLC
Sinopharm
Sanofi
Helsinn
Italfarmaco
Chinoin
1 Musculoskeletal Medicine Market Overview
1.1 Product Overview and Scope of Musculoskeletal Medicine
1.2 Classification of Musculoskeletal Medicine by Type
1.2.1 Global Musculoskeletal Medicine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Musculoskeletal Medicine Revenue Market Share by Type in 2019
1.2.3 Tablets
1.2.4 Patch
1.2.5 Capsule
1.2.6 Suppositories
1.2.7 Injection
1.2.8 Suspension Agent
1.2.9 Emplastrum
1.2.10 Granules
1.2.11 Other
1.3 Global Musculoskeletal Medicine Market by Application
1.3.1 Overview: Global Musculoskeletal Medicine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Orthopedic Analgesics
1.3.3 Antipyretic And Analgesic
1.3.4 Nonsteroidal Anti-Inflammatory Drugs
1.3.5 Drugs For Rheumatic Diseases
1.3.6 Gout Drug Resistance
1.3.7 Medication For Bruising Injuries
1.3.8 Myasthenia Gravis Medication
1.3.9 Slow Acting Antirheumatic Agent
1.3.10 Topical Administration For Joint And Muscle Pain
1.3.11 Other
1.4 Global Musculoskeletal Medicine Market by Regions
1.4.1 Global Musculoskeletal Medicine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Musculoskeletal Medicine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Musculoskeletal Medicine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Musculoskeletal Medicine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Musculoskeletal Medicine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Musculoskeletal Medicine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Musculoskeletal Medicine Status and Prospect (2015-2025)
2 Company Profiles
2.1 Mylan N.V.
2.1.1 Mylan N.V. Details
2.1.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Mylan N.V. SWOT Analysis
2.1.4 Mylan N.V. Product and Services
2.1.5 Mylan N.V. Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dr. Reddy’s Laboratories Ltd.
2.2.1 Dr. Reddy’s Laboratories Ltd. Details
2.2.2 Dr. Reddy’s Laboratories Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dr. Reddy’s Laboratories Ltd. SWOT Analysis
2.2.4 Dr. Reddy’s Laboratories Ltd. Product and Services
2.2.5 Dr. Reddy’s Laboratories Ltd. Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis Pharmaceuticals
2.3.1 Novartis Pharmaceuticals Details
2.3.2 Novartis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis Pharmaceuticals SWOT Analysis
2.3.4 Novartis Pharmaceuticals Product and Services
2.3.5 Novartis Pharmaceuticals Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva Pharmaceutical Industries Ltd
2.4.1 Teva Pharmaceutical Industries Ltd Details
2.4.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.4.4 Teva Pharmaceutical Industries Ltd Product and Services
2.4.5 Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.5 Valeant Pharmaceuticals International, Inc
2.5.1 Valeant Pharmaceuticals International, Inc Details
2.5.2 Valeant Pharmaceuticals International, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Valeant Pharmaceuticals International, Inc SWOT Analysis
2.5.4 Valeant Pharmaceuticals International, Inc Product and Services
2.5.5 Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.6 UCB S.A.
2.6.1 UCB S.A. Details
2.6.2 UCB S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 UCB S.A. SWOT Analysis
2.6.4 UCB S.A. Product and Services
2.6.5 UCB S.A. Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sawai PharmaceuticalCo., Ltd
2.7.1 Sawai PharmaceuticalCo., Ltd Details
2.7.2 Sawai PharmaceuticalCo., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sawai PharmaceuticalCo., Ltd SWOT Analysis
2.7.4 Sawai PharmaceuticalCo., Ltd Product and Services
2.7.5 Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hospira Inc
2.8.1 Hospira Inc Details
2.8.2 Hospira Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Hospira Inc SWOT Analysis
2.8.4 Hospira Inc Product and Services
2.8.5 Hospira Inc Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche Inc
2.9.1 Roche Inc Details
2.9.2 Roche Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche Inc SWOT Analysis
2.9.4 Roche Inc Product and Services
2.9.5 Roche Inc Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sun Pharmaceutical Industries Ltd. Co. , Ltd
2.10.1 Sun Pharmaceutical Industries Ltd. Co. , Ltd Details
2.10.2 Sun Pharmaceutical Industries Ltd. Co. , Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sun Pharmaceutical Industries Ltd. Co. , Ltd SWOT Analysis
2.10.4 Sun Pharmaceutical Industries Ltd. Co. , Ltd Product and Services
2.10.5 Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck SWOT Analysis
2.11.4 Merck Product and Services
2.11.5 Merck Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.12 Bayer
2.12.1 Bayer Details
2.12.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Bayer SWOT Analysis
2.12.4 Bayer Product and Services
2.12.5 Bayer Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.13 Endo International
2.13.1 Endo International Details
2.13.2 Endo International Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Endo International SWOT Analysis
2.13.4 Endo International Product and Services
2.13.5 Endo International Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.14 Grunenthal
2.14.1 Grunenthal Details
2.14.2 Grunenthal Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Grunenthal SWOT Analysis
2.14.4 Grunenthal Product and Services
2.14.5 Grunenthal Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.15 GSK
2.15.1 GSK Details
2.15.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 GSK SWOT Analysis
2.15.4 GSK Product and Services
2.15.5 GSK Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.16 Boehringer Ingelheim
2.16.1 Boehringer Ingelheim Details
2.16.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Boehringer Ingelheim SWOT Analysis
2.16.4 Boehringer Ingelheim Product and Services
2.16.5 Boehringer Ingelheim Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hikma Pharmaceuticals
2.17.1 Hikma Pharmaceuticals Details
2.17.2 Hikma Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hikma Pharmaceuticals SWOT Analysis
2.17.4 Hikma Pharmaceuticals Product and Services
2.17.5 Hikma Pharmaceuticals Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.18 Rafa Laboratories
2.18.1 Rafa Laboratories Details
2.18.2 Rafa Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Rafa Laboratories SWOT Analysis
2.18.4 Rafa Laboratories Product and Services
2.18.3 Rafa Laboratories Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.19 Alter
2.19.1 Alter Details
2.19.2 Alter Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Alter SWOT Analysis
2.19.4 Alter Product and Services
2.19.5 Alter Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.20 Fresenius Kabi, LLC
2.20.1 Fresenius Kabi, LLC Details
2.20.2 Fresenius Kabi, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Fresenius Kabi, LLC SWOT Analysis
2.20.4 Fresenius Kabi, LLC Product and Services
2.20.5 Fresenius Kabi, LLC Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.21 CorePharma
2.21.1 CorePharma Details
2.21.2 CorePharma Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 CorePharma SWOT Analysis
2.21.4 CorePharma Product and Services
2.21.5 CorePharma Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.22 Pfizer
2.22.1 Pfizer Details
2.22.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Pfizer SWOT Analysis
2.22.4 Pfizer Product and Services
2.22.5 Pfizer Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.23 Apotex Inc
2.23.1 Apotex Inc Details
2.23.2 Apotex Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Apotex Inc SWOT Analysis
2.23.4 Apotex Inc Product and Services
2.23.5 Apotex Inc Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.24 Acorda Therapeutics
2.24.1 Acorda Therapeutics Details
2.24.2 Acorda Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Acorda Therapeutics SWOT Analysis
2.24.4 Acorda Therapeutics Product and Services
2.24.5 Acorda Therapeutics Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.25 Therabel
2.25.1 Therabel Details
2.25.2 Therabel Major Business and Total Revenue (Financial Highlights) Analysis
2.25.3 Therabel SWOT Analysis
2.25.4 Therabel Product and Services
2.25.5 Therabel Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.26 Martec USA LLC
2.26.1 Martec USA LLC Details
2.26.2 Martec USA LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.26.3 Martec USA LLC SWOT Analysis
2.26.4 Martec USA LLC Product and Services
2.26.5 Martec USA LLC Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.27 Sinopharm
2.27.1 Sinopharm Details
2.27.2 Sinopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.27.3 Sinopharm SWOT Analysis
2.27.4 Sinopharm Product and Services
2.27.5 Sinopharm Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.28 Sanofi
2.28.1 Sanofi Details
2.28.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.28.3 Sanofi SWOT Analysis
2.28.4 Sanofi Product and Services
2.28.5 Sanofi Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.29 Helsinn
2.29.1 Helsinn Details
2.29.2 Helsinn Major Business and Total Revenue (Financial Highlights) Analysis
2.29.3 Helsinn SWOT Analysis
2.29.4 Helsinn Product and Services
2.29.5 Helsinn Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.30 Italfarmaco
2.30.1 Italfarmaco Details
2.30.2 Italfarmaco Major Business and Total Revenue (Financial Highlights) Analysis
2.30.3 Italfarmaco SWOT Analysis
2.30.4 Italfarmaco Product and Services
2.30.5 Italfarmaco Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.31 Chinoin
2.31.1 Chinoin Details
2.31.2 Chinoin Major Business and Total Revenue (Financial Highlights) Analysis
2.31.3 Chinoin SWOT Analysis
2.31.4 Chinoin Product and Services
2.31.5 Chinoin Musculoskeletal Medicine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Musculoskeletal Medicine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Musculoskeletal Medicine Players Market Share
3.2.2 Top 10 Musculoskeletal Medicine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Musculoskeletal Medicine Revenue and Market Share by Regions
4.2 North America Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
4.3 Europe Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
4.5 South America Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
5 North America Musculoskeletal Medicine Revenue by Countries
5.1 North America Musculoskeletal Medicine Revenue by Countries (2015-2020)
5.2 USA Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
5.3 Canada Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
5.4 Mexico Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
6 Europe Musculoskeletal Medicine Revenue by Countries
6.1 Europe Musculoskeletal Medicine Revenue by Countries (2015-2020)
6.2 Germany Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
6.3 UK Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
6.4 France Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
6.5 Russia Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
6.6 Italy Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Musculoskeletal Medicine Revenue by Countries
7.1 Asia-Pacific Musculoskeletal Medicine Revenue by Countries (2015-2020)
7.2 China Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
7.3 Japan Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
7.4 Korea Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
7.5 India Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
8 South America Musculoskeletal Medicine Revenue by Countries
8.1 South America Musculoskeletal Medicine Revenue by Countries (2015-2020)
8.2 Brazil Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
8.3 Argentina Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Musculoskeletal Medicine by Countries
9.1 Middle East & Africa Musculoskeletal Medicine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
9.3 UAE Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
9.4 Egypt Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
9.5 South Africa Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Musculoskeletal Medicine Revenue and Market Share by Type (2015-2020)
10.2 Global Musculoskeletal Medicine Market Forecast by Type (2019-2024)
10.3 Tablets Revenue Growth Rate (2015-2025)
10.4 Patch Revenue Growth Rate (2015-2025)
10.5 Capsule Revenue Growth Rate (2015-2025)
10.6 Suppositories Revenue Growth Rate (2015-2025)
10.7 Injection Revenue Growth Rate (2015-2025)
10.8 Suspension Agent Revenue Growth Rate (2015-2025)
10.9 Emplastrum Revenue Growth Rate (2015-2025)
10.10 Granules Revenue Growth Rate (2015-2025)
10.11 Other Revenue Growth Rate (2015-2025)
11 Global Musculoskeletal Medicine Market Segment by Application
11.1 Global Musculoskeletal Medicine Revenue Market Share by Application (2015-2020)
11.2 Musculoskeletal Medicine Market Forecast by Application (2019-2024)
11.3 Orthopedic Analgesics Revenue Growth (2015-2020)
11.4 Antipyretic And Analgesic Revenue Growth (2015-2020)
11.5 Nonsteroidal Anti-Inflammatory Drugs Revenue Growth (2015-2020)
11.6 Drugs For Rheumatic Diseases Revenue Growth (2015-2020)
11.7 Gout Drug Resistance Revenue Growth (2015-2020)
11.8 Medication For Bruising Injuries Revenue Growth (2015-2020)
11.9 Myasthenia Gravis Medication Revenue Growth (2015-2020)
11.10 Slow Acting Antirheumatic Agent Revenue Growth (2015-2020)
11.11 Topical Administration For Joint And Muscle Pain Revenue Growth (2015-2020)
11.12 Other Revenue Growth (2015-2020)
12 Global Musculoskeletal Medicine Market Size Forecast (2021-2025)
12.1 Global Musculoskeletal Medicine Market Size Forecast (2021-2025)
12.2 Global Musculoskeletal Medicine Market Forecast by Regions (2021-2025)
12.3 North America Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
12.4 Europe Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
12.6 South America Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Musculoskeletal Medicine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Musculoskeletal Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Musculoskeletal Medicine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Musculoskeletal Medicine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Mylan N.V. Corporate Information, Location and Competitors
Table 6. Mylan N.V. Musculoskeletal Medicine Major Business
Table 7. Mylan N.V. Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 8. Mylan N.V. SWOT Analysis
Table 9. Mylan N.V. Musculoskeletal Medicine Product and Solutions
Table 10. Mylan N.V. Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Dr. Reddy's Laboratories Ltd. Corporate Information, Location and Competitors
Table 12. Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Major Business
Table 13. Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Total Revenue (USD Million) (2018-2019)
Table 14. Dr. Reddy's Laboratories Ltd. SWOT Analysis
Table 15. Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Product and Solutions
Table 16. Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Novartis Pharmaceuticals Musculoskeletal Medicine Major Business
Table 19. Novartis Pharmaceuticals Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 20. Novartis Pharmaceuticals SWOT Analysis
Table 21. Novartis Pharmaceuticals Musculoskeletal Medicine Product and Solutions
Table 22. Novartis Pharmaceuticals Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Teva Pharmaceutical Industries Ltd Corporate Information, Location and Competitors
Table 24. Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Major Business
Table 25. Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 26. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 27. Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Product and Solutions
Table 28. Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Valeant Pharmaceuticals International, Inc Corporate Information, Location and Competitors
Table 30. Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Major Business
Table 31. Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 32. Valeant Pharmaceuticals International, Inc SWOT Analysis
Table 33. Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Product and Solutions
Table 34. Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. UCB S.A. Corporate Information, Location and Competitors
Table 36. UCB S.A. Musculoskeletal Medicine Major Business
Table 37. UCB S.A. Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 38. UCB S.A. SWOT Analysis
Table 39. UCB S.A. Musculoskeletal Medicine Product and Solutions
Table 40. UCB S.A. Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sawai PharmaceuticalCo., Ltd Corporate Information, Location and Competitors
Table 42. Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Major Business
Table 43. Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 44. Sawai PharmaceuticalCo., Ltd SWOT Analysis
Table 45. Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Product and Solutions
Table 46. Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Hospira Inc Corporate Information, Location and Competitors
Table 48. Hospira Inc Musculoskeletal Medicine Major Business
Table 49. Hospira Inc Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 50. Hospira Inc SWOT Analysis
Table 51. Hospira Inc Musculoskeletal Medicine Product and Solutions
Table 52. Hospira Inc Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Inc Corporate Information, Location and Competitors
Table 54. Roche Inc Musculoskeletal Medicine Major Business
Table 55. Roche Inc Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 56. Roche Inc SWOT Analysis
Table 57. Roche Inc Musculoskeletal Medicine Product and Solutions
Table 58. Roche Inc Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sun Pharmaceutical Industries Ltd. Co. , Ltd Corporate Information, Location and Competitors
Table 60. Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Major Business
Table 61. Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 62. Sun Pharmaceutical Industries Ltd. Co. , Ltd SWOT Analysis
Table 63. Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Product and Solutions
Table 64. Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Merck Corporate Information, Location and Competitors
Table 66. Merck Musculoskeletal Medicine Major Business
Table 67. Merck Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 68. Merck SWOT Analysis
Table 69. Merck Musculoskeletal Medicine Product and Solutions
Table 70. Merck Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Bayer Corporate Information, Location and Competitors
Table 72. Bayer Musculoskeletal Medicine Major Business
Table 73. Bayer Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 74. Bayer SWOT Analysis
Table 75. Bayer Musculoskeletal Medicine Product and Solutions
Table 76. Bayer Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Endo International Corporate Information, Location and Competitors
Table 78. Endo International Musculoskeletal Medicine Major Business
Table 79. Endo International Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 80. Endo International SWOT Analysis
Table 81. Endo International Musculoskeletal Medicine Product and Solutions
Table 82. Endo International Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Grunenthal Corporate Information, Location and Competitors
Table 84. Grunenthal Musculoskeletal Medicine Major Business
Table 85. Grunenthal Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 86. Grunenthal SWOT Analysis
Table 87. Grunenthal Musculoskeletal Medicine Product and Solutions
Table 88. Grunenthal Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. GSK Corporate Information, Location and Competitors
Table 90. GSK Musculoskeletal Medicine Major Business
Table 91. GSK Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 92. GSK SWOT Analysis
Table 93. GSK Musculoskeletal Medicine Product and Solutions
Table 94. GSK Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 96. Boehringer Ingelheim Musculoskeletal Medicine Major Business
Table 97. Boehringer Ingelheim Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 98. Boehringer Ingelheim SWOT Analysis
Table 99. Boehringer Ingelheim Musculoskeletal Medicine Product and Solutions
Table 100. Boehringer Ingelheim Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Hikma Pharmaceuticals Corporate Information, Location and Competitors
Table 102. Hikma Pharmaceuticals Musculoskeletal Medicine Major Business
Table 103. Hikma Pharmaceuticals Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 104. Hikma Pharmaceuticals SWOT Analysis
Table 105. Hikma Pharmaceuticals Musculoskeletal Medicine Product and Solutions
Table 106. Hikma Pharmaceuticals Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Rafa Laboratories Musculoskeletal Medicine Type and Application
Table 108. Rafa Laboratories Musculoskeletal Medicine Major Business
Table 109. Rafa Laboratories Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 110. Rafa Laboratories SWOT Analysis
Table 111. Rafa Laboratories Musculoskeletal Medicine Product and Solutions
Table 112. Rafa Laboratories Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Alter Corporate Information, Location and Competitors
Table 114. Alter Musculoskeletal Medicine Major Business
Table 115. Alter Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 116. Alter SWOT Analysis
Table 117. Alter Musculoskeletal Medicine Product and Solutions
Table 118. Alter Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Fresenius Kabi, LLC Corporate Information, Location and Competitors
Table 120. Fresenius Kabi, LLC Musculoskeletal Medicine Major Business
Table 121. Fresenius Kabi, LLC Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 122. Fresenius Kabi, LLC SWOT Analysis
Table 123. Fresenius Kabi, LLC Musculoskeletal Medicine Product and Solutions
Table 124. Fresenius Kabi, LLC Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. CorePharma Corporate Information, Location and Competitors
Table 126. CorePharma Musculoskeletal Medicine Major Business
Table 127. CorePharma Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 128. CorePharma SWOT Analysis
Table 129. CorePharma Musculoskeletal Medicine Product and Solutions
Table 130. CorePharma Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Pfizer Corporate Information, Location and Competitors
Table 132. Pfizer Musculoskeletal Medicine Major Business
Table 133. Pfizer Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 134. Pfizer SWOT Analysis
Table 135. Pfizer Musculoskeletal Medicine Product and Solutions
Table 136. Pfizer Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Apotex Inc Corporate Information, Location and Competitors
Table 138. Apotex Inc Musculoskeletal Medicine Major Business
Table 139. Apotex Inc Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 140. Apotex Inc SWOT Analysis
Table 141. Apotex Inc Musculoskeletal Medicine Product and Solutions
Table 142. Apotex Inc Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 143. Acorda Therapeutics Corporate Information, Location and Competitors
Table 144. Acorda Therapeutics Musculoskeletal Medicine Major Business
Table 145. Acorda Therapeutics Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 146. Acorda Therapeutics SWOT Analysis
Table 147. Acorda Therapeutics Musculoskeletal Medicine Product and Solutions
Table 148. Acorda Therapeutics Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 149. Therabel Corporate Information, Location and Competitors
Table 150. Therabel Musculoskeletal Medicine Major Business
Table 151. Therabel Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 152. Therabel SWOT Analysis
Table 153. Therabel Musculoskeletal Medicine Product and Solutions
Table 154. Therabel Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 155. Martec USA LLC Corporate Information, Location and Competitors
Table 156. Martec USA LLC Musculoskeletal Medicine Major Business
Table 157. Martec USA LLC Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 158. Martec USA LLC SWOT Analysis
Table 159. Martec USA LLC Musculoskeletal Medicine Product and Solutions
Table 160. Martec USA LLC Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 161. Sinopharm Corporate Information, Location and Competitors
Table 162. Sinopharm Musculoskeletal Medicine Major Business
Table 163. Sinopharm Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 164. Sinopharm SWOT Analysis
Table 165. Sinopharm Musculoskeletal Medicine Product and Solutions
Table 166. Sinopharm Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 167. Sanofi Corporate Information, Location and Competitors
Table 168. Sanofi Musculoskeletal Medicine Major Business
Table 169. Sanofi Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 170. Sanofi SWOT Analysis
Table 171. Sanofi Musculoskeletal Medicine Product and Solutions
Table 172. Sanofi Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 173. Helsinn Corporate Information, Location and Competitors
Table 174. Helsinn Musculoskeletal Medicine Major Business
Table 175. Helsinn Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 176. Helsinn SWOT Analysis
Table 177. Helsinn Musculoskeletal Medicine Product and Solutions
Table 178. Helsinn Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 179. Italfarmaco Corporate Information, Location and Competitors
Table 180. Italfarmaco Musculoskeletal Medicine Major Business
Table 181. Italfarmaco Musculoskeletal Medicine Total Revenue (USD Million) (2017-2018)
Table 182. Italfarmaco SWOT Analysis
Table 183. Italfarmaco Musculoskeletal Medicine Product and Solutions
Table 184. Italfarmaco Musculoskeletal Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 185. Global Musculoskeletal Medicine Revenue (Million USD) by Players (2015-2020)
Table 186. Global Musculoskeletal Medicine Revenue Share by Players (2015-2020)
Table 187. Global Musculoskeletal Medicine Revenue (Million USD) by Regions (2015-2020)
Table 188. Global Musculoskeletal Medicine Revenue Market Share by Regions (2015-2020)
Table 189. North America Musculoskeletal Medicine Revenue by Countries (2015-2020)
Table 190. North America Musculoskeletal Medicine Revenue Market Share by Countries (2015-2020)
Table 191. Europe Musculoskeletal Medicine Revenue (Million USD) by Countries (2015-2020)
Table 192. Asia-Pacific Musculoskeletal Medicine Revenue (Million USD) by Countries (2015-2020)
Table 193. South America Musculoskeletal Medicine Revenue by Countries (2015-2020)
Table 194. South America Musculoskeletal Medicine Revenue Market Share by Countries (2015-2020)
Table 195. Middle East and Africa Musculoskeletal Medicine Revenue (Million USD) by Countries (2015-2020)
Table 196. Middle East and Africa Musculoskeletal Medicine Revenue Market Share by Countries (2015-2020)
Table 197. Global Musculoskeletal Medicine Revenue (Million USD) by Type (2015-2020)
Table 198. Global Musculoskeletal Medicine Revenue Share by Type (2015-2020)
Table 199. Global Musculoskeletal Medicine Revenue Forecast by Type (2021-2025)
Table 200. Global Musculoskeletal Medicine Revenue by Application (2015-2020)
Table 201. Global Musculoskeletal Medicine Revenue Share by Application (2015-2020)
Table 202. Global Musculoskeletal Medicine Revenue Forecast by Application (2021-2025)
Table 203. Global Musculoskeletal Medicine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Musculoskeletal Medicine Picture
Figure 2. Global Musculoskeletal Medicine Revenue Market Share by Type in 2019
Figure 3. Tablets Picture
Figure 4. Patch Picture
Figure 5. Capsule Picture
Figure 6. Suppositories Picture
Figure 7. Injection Picture
Figure 8. Suspension Agent Picture
Figure 9. Emplastrum Picture
Figure 10. Granules Picture
Figure 11. Other Picture
Figure 12. Musculoskeletal Medicine Revenue Market Share by Application in 2019
Figure 13. Orthopedic Analgesics Picture
Figure 14. Antipyretic And Analgesic Picture
Figure 15. Nonsteroidal Anti-Inflammatory Drugs Picture
Figure 16. Drugs For Rheumatic Diseases Picture
Figure 17. Gout Drug Resistance Picture
Figure 18. Medication For Bruising Injuries Picture
Figure 19. Myasthenia Gravis Medication Picture
Figure 20. Slow Acting Antirheumatic Agent Picture
Figure 21. Topical Administration For Joint And Muscle Pain Picture
Figure 22. Global Musculoskeletal Medicine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 23. North America Musculoskeletal Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Europe Musculoskeletal Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Asia-Pacific Musculoskeletal Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 26. South America Musculoskeletal Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 27. Middle East and Africa Musculoskeletal Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 28. Global Musculoskeletal Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 29. Global Musculoskeletal Medicine Revenue Share by Players in 2019
Figure 30. Global Top 5 Players Musculoskeletal Medicine Revenue Market Share in 2019
Figure 31. Global Top 10 Players Musculoskeletal Medicine Revenue Market Share in 2019
Figure 32. Key Players Market Share Trend
Figure 33. Global Musculoskeletal Medicine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 34. Global Musculoskeletal Medicine Revenue Market Share by Regions (2015-2020)
Figure 35. Global Musculoskeletal Medicine Revenue Market Share by Regions in 2018
Figure 36. North America Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 37. Europe Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 38. Asia-Pacific Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 39. South America Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 40. Middle East and Africa Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 41. North America Musculoskeletal Medicine Revenue Market Share by Countries (2015-2020)
Figure 42. North America Musculoskeletal Medicine Revenue Market Share by Countries in 2019
Figure 43. USA Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 44. Canada Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 45. Mexico Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 46. Europe Musculoskeletal Medicine Revenue Market Share by Countries (2015-2020)
Figure 47. Europe Musculoskeletal Medicine Revenue Market Share by Countries in 2019
Figure 48. Germany Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 49. UK Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 50. France Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 51. Russia Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 52. Italy Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 53. Asia-Pacific Musculoskeletal Medicine Revenue Market Share by Countries (2015-2020)
Figure 54. Asia-Pacific Musculoskeletal Medicine Revenue Market Share by Countries in 2019
Figure 55. China Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 56. Japan Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 57. Korea Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 58. India Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 59. Southeast Asia Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 60. South America Musculoskeletal Medicine Revenue Market Share by Countries (2015-2020)
Figure 61. South America Musculoskeletal Medicine Revenue Market Share by Countries in 2019
Figure 62. Brazil Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 63. Argentina Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 64. Middle East and Africa Musculoskeletal Medicine Revenue Market Share by Countries (2015-2020)
Figure 65. Middle East and Africa Musculoskeletal Medicine Revenue Market Share by Countries in 2019
Figure 66. Saudi Arabia Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 67. UAE Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 68. Egypt Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 69. South Africa Musculoskeletal Medicine Revenue and Growth Rate (2015-2020)
Figure 70. Global Musculoskeletal Medicine Revenue Share by Type (2015-2020)
Figure 71. Global Musculoskeletal Medicine Revenue Share by Type in 2019
Figure 72. Global Musculoskeletal Medicine Market Share Forecast by Type (2021-2025)
Figure 73. Global Tablets Revenue Growth Rate (2015-2020)
Figure 74. Global Patch Revenue Growth Rate (2015-2020)
Figure 75. Global Capsule Revenue Growth Rate (2015-2020)
Figure 76. Global Suppositories Revenue Growth Rate (2015-2020)
Figure 77. Global Injection Revenue Growth Rate (2015-2020)
Figure 78. Global Suspension Agent Revenue Growth Rate (2015-2020)
Figure 79. Global Emplastrum Revenue Growth Rate (2015-2020)
Figure 80. Global Granules Revenue Growth Rate (2015-2020)
Figure 81. Global Other Revenue Growth Rate (2015-2020)
Figure 82. Global Musculoskeletal Medicine Revenue Share by Application (2015-2020)
Figure 83. Global Musculoskeletal Medicine Revenue Share by Application in 2019
Figure 84. Global Musculoskeletal Medicine Market Share Forecast by Application (2021-2025)
Figure 85. Global Orthopedic Analgesics Revenue Growth Rate (2015-2020)
Figure 86. Global Antipyretic And Analgesic Revenue Growth Rate (2015-2020)
Figure 87. Global Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2015-2020)
Figure 88. Global Drugs For Rheumatic Diseases Revenue Growth Rate (2015-2020)
Figure 89. Global Gout Drug Resistance Revenue Growth Rate (2015-2020)
Figure 90. Global Medication For Bruising Injuries Revenue Growth Rate (2015-2020)
Figure 91. Global Myasthenia Gravis Medication Revenue Growth Rate (2015-2020)
Figure 92. Global Slow Acting Antirheumatic Agent Revenue Growth Rate (2015-2020)
Figure 93. Global Topical Administration For Joint And Muscle Pain Revenue Growth Rate (2015-2020)
Figure 94. Global Other Revenue Growth Rate (2015-2020)
Figure 95. Global Musculoskeletal Medicine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 96. Global Musculoskeletal Medicine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 97. Global Musculoskeletal Medicine Revenue Market Share Forecast by Regions (2021-2025)
Figure 98. North America Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
Figure 99. Europe Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
Figure 100. Asia-Pacific Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
Figure 101. South America Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
Figure 102. Middle East and Africa Musculoskeletal Medicine Revenue Market Forecast (2021-2025)
Figure 103. Sales Channel: Direct Channel vs Indirect Channel
予防医学の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Preventive Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Preventive Medicine marke…- 眼科用薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Ophthalmic Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 核医学診断（SPECTおよびPET）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Medicine Diagnostic (SPECT and PET) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The N…
- 薬収納キャビネットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medicine Storage Cabinet market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Medicine Storage Cab…
- アヒル用薬・ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Duck Medicine and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…